This site is intended only for healthcare professionals resident in the Republic of Ireland
Menu
Close
Menu
Close
Pfizer has a long-standing commitment to tackling antimicrobial resistance (AMR), as well as a willingness to collaborate with external stakeholders. Initiatives currently focus on an extensive range of programmes that go beyond the sale of our medicines, including; public awareness and educational programmes, education of healthcare professionals, responsible commercial and manufacturing activities and investment in surveillance programmes.
Pfizer is proud to have been recognized as the joint industry leader in the Access to Medicine Foundation’s 2021 AMR Benchmark Report, with the report highlighting our industry-leading policies to improve appropriate access to our medicines and curb the threat of AMR. We performed strongly in R&D, Responsible Manufacturing and Appropriate Access, were ranked leaders in Stewardship, and were commended for being the first pharmaceutical company to publicly share raw surveillance data from our antimicrobial surveillance website platform, the Antimicrobial Testing Leadership and Surveillance (ATLAS) database.1
Adverse events should be reported. Report an adverse event to your national reporting system (HPRA Pharmacovigilance)
Adverse events should also be reported to Pfizer Medical Information on 1800 633 363
Please sign in or register to gain access to information relating to Pfizer medicines and vaccines, medical conditions, patient materials and services.
This site is intended only for healthcare professionals resident in the Republic of Ireland. If you are a member of the public wishing to access information on a specific medicine, please visit https://www.medicines.ie
This website is brought to you by Pfizer Healthcare Ireland, 9 Riverwalk, National Digital Park, Citywest Business Campus, Dublin 24, Ireland. Registered in the Republic of Ireland No. 127002.
Copyright © 2023 Pfizer Limited. All rights reserved.
The information contained on this site is reserved exclusively for healthcare professionals resident in the Republic of Ireland.
I confirm that I am a healthcare professional resident in the Republic of Ireland.*
I accept and agree to the terms of use.*
If you select 'No', you will be redirected to Pfizer.ie, where you will be able to access information on Pfizer Healthcare Ireland.
PP-UNP-IRL-0176. January 2023